Episentec completes financing round

We are proud to announce the successful completion of a financing round with contributions from Almi Innovationsbron AB and a number of private investors, and also from the existing owners.

We will now step up the activities and change the focus of the operations. After two successful years of product development and application development together with selected pilot customers, the focus will now be on marketing and sales and on customer application support. In addition to our established product lines – Episentec reagents and EpiGrammer software – we will also be offering labelling & purification services and SPR method development services.

We are looking forward to many rewarding meetings with new – and old! – customers and the development of many new, exciting applications based on our proprietary Label-Enhanced SPR technology.

For further information please contact Anders Hanning, CEO anders.hanning@episentec.com .